IL151787A0 - 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents - Google Patents

4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents

Info

Publication number
IL151787A0
IL151787A0 IL15178701A IL15178701A IL151787A0 IL 151787 A0 IL151787 A0 IL 151787A0 IL 15178701 A IL15178701 A IL 15178701A IL 15178701 A IL15178701 A IL 15178701A IL 151787 A0 IL151787 A0 IL 151787A0
Authority
IL
Israel
Prior art keywords
cinnolinecarboxamides
dihydro
oxo
antiviral agents
antiviral
Prior art date
Application number
IL15178701A
Other languages
English (en)
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of IL151787A0 publication Critical patent/IL151787A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/28Cinnolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL15178701A 2000-03-21 2001-03-15 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents IL151787A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19129100P 2000-03-21 2000-03-21
PCT/US2001/005811 WO2001070706A2 (en) 2000-03-21 2001-03-15 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents

Publications (1)

Publication Number Publication Date
IL151787A0 true IL151787A0 (en) 2003-04-10

Family

ID=22704885

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15178701A IL151787A0 (en) 2000-03-21 2001-03-15 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents

Country Status (28)

Country Link
US (1) US6624160B2 (hu)
EP (1) EP1265873B1 (hu)
JP (1) JP2003528087A (hu)
KR (1) KR20020081479A (hu)
CN (1) CN1406228A (hu)
AR (1) AR027978A1 (hu)
AT (1) ATE252086T1 (hu)
AU (1) AU2001247224A1 (hu)
BR (1) BR0109487A (hu)
CA (1) CA2400000A1 (hu)
CZ (1) CZ20023141A3 (hu)
DE (1) DE60100999T2 (hu)
DK (1) DK1265873T3 (hu)
EA (1) EA200201002A1 (hu)
EE (1) EE200200541A (hu)
ES (1) ES2208581T3 (hu)
HK (1) HK1052694A1 (hu)
HU (1) HUP0300326A3 (hu)
IL (1) IL151787A0 (hu)
MX (1) MXPA02009251A (hu)
NO (1) NO20024502L (hu)
NZ (1) NZ521524A (hu)
PL (1) PL357443A1 (hu)
PT (1) PT1265873E (hu)
SI (1) SI1265873T1 (hu)
SK (1) SK12102002A3 (hu)
WO (1) WO2001070706A2 (hu)
ZA (1) ZA200207540B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20011349A1 (es) * 2000-06-16 2002-01-19 Upjohn Co 1-aril-4-oxo-1,4-dihidro-3-quinolincarboxamidas como agentes antivirales
WO2014070976A1 (en) * 2012-11-03 2014-05-08 Boehringer Ingelheim International Gmbh Inhibitors of cytomegalovirus
CA3112326A1 (en) 2018-09-12 2020-03-19 Novartis Ag Antiviral pyridopyrazinedione compounds
CN114667285A (zh) 2019-09-26 2022-06-24 诺华股份有限公司 抗病毒吡唑并吡啶酮化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8513639D0 (en) 1985-05-30 1985-07-03 Ici America Inc Cinnoline compounds
GB8702288D0 (en) * 1987-02-02 1987-03-11 Erba Farmitalia Cinnoline-carboxamides
PT841929E (pt) 1995-08-02 2003-09-30 Darwin Discovery Ltd Quinolonas e sua utilizacao terapeutica
AU695132B2 (en) 1995-08-02 1998-08-06 Darwin Discovery Limited Quinolones and their therapeutic use
BR9814323A (pt) 1997-12-22 2004-06-29 Upjohn Co 4-hidroxiquinolina-3-carboxamidas e hidrazidas como agentes antiviróticos
AU763636C (en) 1998-01-29 2004-05-27 Daiichi Asubio Pharma Co., Ltd. 1-cycloalkyl-1,8-naphthyridin-4-one derivatives with phosphodiesterase IV inhibitory activity

Also Published As

Publication number Publication date
CN1406228A (zh) 2003-03-26
EA200201002A1 (ru) 2003-02-27
PL357443A1 (en) 2004-07-26
DE60100999T2 (de) 2004-09-02
CA2400000A1 (en) 2001-09-27
SK12102002A3 (sk) 2003-03-04
HUP0300326A3 (en) 2003-09-29
MXPA02009251A (es) 2004-04-05
ZA200207540B (en) 2003-12-19
US20020045619A1 (en) 2002-04-18
EE200200541A (et) 2004-04-15
WO2001070706A3 (en) 2002-05-10
EP1265873B1 (en) 2003-10-15
SI1265873T1 (en) 2004-02-29
WO2001070706A2 (en) 2001-09-27
CZ20023141A3 (cs) 2003-02-12
KR20020081479A (ko) 2002-10-26
NO20024502D0 (no) 2002-09-20
NZ521524A (en) 2004-04-30
JP2003528087A (ja) 2003-09-24
ES2208581T3 (es) 2004-06-16
HK1052694A1 (zh) 2003-09-26
AU2001247224A1 (en) 2001-10-03
HUP0300326A2 (hu) 2003-07-28
BR0109487A (pt) 2003-06-10
PT1265873E (pt) 2004-03-31
NO20024502L (no) 2002-11-20
DK1265873T3 (da) 2004-02-16
EP1265873A2 (en) 2002-12-18
DE60100999D1 (en) 2003-11-20
AR027978A1 (es) 2003-04-23
US6624160B2 (en) 2003-09-23
ATE252086T1 (de) 2003-11-15

Similar Documents

Publication Publication Date Title
HUP0105142A3 (en) 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
EG23232A (en) Absorbent article.
IL144171A0 (en) Quinolinecarboxamides as antiviral agents
MXPA03002269A (es) Derivados de purina.
AU2002221344A1 (en) Antiviral agents
MXPA03000078A (es) Derivados de purina.
IL161881A (en) N,n'-substituted-1,3-diamino-2- hydroxypropane derivatives
MXPA03004947A (es) Derivados de tetralona como agentes antitumorales.
MXPA03000107A (es) Pirroloquinolonas como agentes antivirales.
EG23262A (en) Delta -pyrrolines.
AU6807501A (en) 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
HK1056872A1 (en) Indoloquinazolinones.
MXPA02005128A (es) Articulos absorbentes adaptables.
SG116454A1 (en) Absorbent article.
HK1052925A1 (en) Substituted 1-aminobutan-3-ol derivatives.
ZA200206151B (en) Substituted amionomethyl-phenyl-cyclohexane derivatives.
ZA200205482B (en) Aminosulfonylbiphenyl derivatives.
HK1054037A1 (zh) 作為抗病毒劑的4-羥基-1,8-二氮雜萘-3-羧酰胺
ZA200206150B (en) Aminomethyl-phenyl-cyclohexanone derivatives.
HK1054235A1 (zh) 作為抗病毒藥的4-氧-1,4-二氫[1,8]-二氮雜萘-3-甲酰胺類
IL151787A0 (en) 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
PL358585A1 (en) N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives
MXPA03002734A (es) Derivados de 5-amino-1-penten-3-ol sustituidos.
HK1039800A1 (en) Stay.
ZA200104710B (en) 4-Oxo-1, 4-dihydro-3-quinolinecarboxamides as antiviral agents.